GO Therapeutics

GO Therapeutics

生物技术研究

Natick,Massachusetts 891 位关注者

Opening the Therapeutic Window for antibody-based cancer therapies

关于我们

GO Therapeutics is exploiting unique aspects of cancer cell biology to develop a new class of cancer therapies for previously intractable solid tumors. We target O-linked glycoproteins specific to cancer cells to develop proprietary, high-affinity antibodies to novel cancer-specific targets. Our antibodies are the basis for a broad array of potent cancer-killing modalities including T-cell bispecifics (TCBs), CAR-T, and antibody drug conjugates (ADCs). Each are designed to kill cancer while sparing healthy tissue.

网站
https://www.gotherapeutics.com
所属行业
生物技术研究
规模
2-10 人
总部
Natick,Massachusetts
类型
私人持股
创立
2014
领域
Drug development、Antigen development、Antobody developement、O-glycosylation、Glycoproteomics、Glycopeptides和Cellular engineering

地点

GO Therapeutics员工

动态

相似主页

查看职位

融资

GO Therapeutics 共 1 轮

上一轮

保密

US$5,000,000.00

Crunchbase 上查看更多信息